Cracking the code of a correlate of protection against SARS-CoV-2 breakthrough infection in cancer patients.
Bron
Scientific reports - ISSN 2045-2322-15:1 (2025) p. 1-15
Cardiovascular toxicities in cancer patients treated with immune checkpoint inhibitors : multicenter study using natural language processing on Belgian hospital data
Bron
ESMO Real World Data and Digital Oncology - ISSN 2949-8201-7 (2025) p. 1-9
Pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy for newly diagnosed, high-risk endometrial cancer : results in mismatch repair-deficient tumors
Bron
Journal of clinical oncology - ISSN 0732-183X-43:3 (2025) p. 1-17
Cisplatin- or carboplatin-based chemotherapy plus pembrolizumab in advanced urothelial cancer : exploratory analysis from the phase 3 KEYNOTE-361 study
Bron
Clinical Genitourinary Cancer - ISSN 1558-7673-23:1 (2025) p. 1-11
Association of tumor mutational burden and PD-L1 with the efficacy of pembrolizumab with or without chemotherapy versus chemotherapy in advanced urothelial carcinoma
Bron
Clinical cancer research - ISSN 1078-0432-30:23 (2024) p. 5353-5364